Related Experiment Video
Updated: Feb 26, 2026
Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
Published on: September 1, 2010
The whole-genome landscape of medulloblastoma subtypes
Paul A Northcott1,2, Ivo Buchhalter3,4,5, A Sorana Morrissy6
1Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Abstract:
Current therapies for medulloblastoma, a highly malignant childhood brain tumour, impose debilitating effects on the developing child, and highlight the need for molecularly targeted treatments with reduced toxicity. Previous studies have been unable to identify the full spectrum of driver genes and molecular processes that operate in medulloblastoma subgroups. Here we analyse the somatic landscape across 491 sequenced medulloblastoma samples and the molecular heterogeneity among 1,256 epigenetically analysed cases, and identify subgroup-specific driver alterations that include previously undiscovered actionable targets. Driver mutations were confidently assigned to most patients belonging to Group 3 and Group 4 medulloblastoma subgroups, greatly enhancing previous knowledge. New molecular subtypes were differentially enriched for specific driver events, including hotspot in-frame insertions that target KBTBD4 and 'enhancer hijacking' events that activate PRDM6. Thus, the application of integrative genomics to an extensive cohort of clinical samples derived from a single childhood cancer entity revealed a series of cancer genes and biologically relevant subtype diversity that represent attractive therapeutic targets for the treatment of patients with medulloblastoma.
Insights
This study identifies new genetic drivers and molecular subtypes in medulloblastoma, a rare childhood brain cancer. These findings offer novel therapeutic targets to improve treatment outcomes and reduce toxicity in affected children.
Area of Science:
- Pediatric Oncology
- Genomics
- Cancer Biology
Background:
- Medulloblastoma is a malignant pediatric brain tumor with debilitating treatment side effects.
- Current therapies lack molecularly targeted approaches, necessitating treatments with reduced toxicity.
- Previous research has not fully elucidated the driver genes and molecular processes across medulloblastoma subgroups.
Purpose of the Study:
- To analyze the somatic and epigenetic landscape of a large cohort of medulloblastoma samples.
- To identify subgroup-specific driver alterations and novel actionable targets.
- To understand molecular heterogeneity and its therapeutic implications in medulloblastoma.
Main Methods:
- Integrative genomics analysis of 491 sequenced medulloblastoma samples.
- Epigenetic analysis of 1,256 medulloblastoma cases.
- Identification and characterization of subgroup-specific driver mutations and molecular events.
Main Results:
- Driver mutations were confidently assigned to most Group 3 and Group 4 medulloblastoma patients.
- New molecular subtypes were identified, enriched for specific driver events like KBTBD4 insertions and PRDM6 enhancer hijacking.
- Expanded knowledge of the molecular landscape and heterogeneity in medulloblastoma.
Conclusions:
- Integrative genomics of a large clinical cohort revealed critical cancer genes and subtype diversity in medulloblastoma.
- Identified novel, biologically relevant therapeutic targets for medulloblastoma treatment.
- Findings pave the way for developing more targeted and less toxic therapies for pediatric medulloblastoma.
More Related Videos
Related Concept Videos
02:21Cancers Originate from Somatic Mutations in a Single Cell
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:17Karyotyping